Tangent Medical report “Tangent Medical, an innovator of IV therapy products, announced it has received CE Mark approval for the NovaCathTM Integrated IV Catheter System. The approval demonstrates that NovaCath meets the safety, health and environmental requirements in the European Union and clears the company to introduce NovaCath throughout Europe and other countries recognizing the CE Mark.”
Tangent Medical receives CE mark for the NovaCath Integrated IV Catheter System http://ctt.ec/Fp1GL+ @ivteam #ivteam
Other intravenous and vascular access resources that may be of interest (External links – IVTEAM has no responsibility for content).
- Guide for intravenous chemotherapy and associated vascular access devices from Macmillan.
- CancerUK IV chemotherapy information.